Protocol for mapping physiological DSBs using in-suspension break labeling in situ and sequencing

Osama Hidmi1, Sara Oster1, Diala Shatleh1

  • 1The Concern Foundation Laboratories, The Lautenberg Center for Immunology and Cancer Research, Department of Immunology and Cancer Research-IMRIC, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.

STAR Protocols
|May 8, 2024
PubMed
Summary

This study introduces a new method, single-nucleotide resolution in-suspension break labeling in situ and sequencing (sBLISS), to map physiological double-stranded breaks (DSBs). This technique aids in understanding genomic instability and DSB formation.